GH Research to Present at ECNP Meeting
Ticker: GHRS · Form: 6-K · Filed: Oct 9, 2025 · CIK: 1855129
Sentiment: neutral
Topics: conference-participation, r&d-update, foreign-private-issuer
TL;DR
GH Research is heading to Amsterdam for the ECNP meeting Oct 11-14, expect updates.
AI Summary
GH Research PLC announced its participation in the 38th European College of Neuropsychopharmacology (ECNP) annual meeting, scheduled for October 11-14, 2025, in Amsterdam, the Netherlands. The company will present information related to its research and development activities at this event.
Why It Matters
Participation in major scientific conferences like ECNP allows GH Research to share its latest findings and engage with the scientific community, potentially impacting its future research direction and partnerships.
Risk Assessment
Risk Level: low — This filing is an announcement of participation in a conference, which typically carries low immediate risk.
Key Players & Entities
- GH Research PLC (company) — Registrant
- 38th European College of Neuropsychopharmacology (ECNP) annual meeting (event) — Conference participation
- October 11-14, 2025 (date) — ECNP meeting dates
- Amsterdam, the Netherlands (location) — ECNP meeting location
FAQ
What is the purpose of GH Research PLC's participation in the ECNP annual meeting?
GH Research PLC announced its participation to present information related to its research and development activities at the 38th ECNP annual meeting.
When and where is the 38th ECNP annual meeting taking place?
The meeting is scheduled to take place from October 11-14, 2025, in Amsterdam, the Netherlands.
What form is GH Research PLC filing with the SEC?
GH Research PLC is filing a Form 6-K, which is a Report of Foreign Private Issuer.
Does GH Research PLC file annual reports under Form 20-F or 40-F?
GH Research PLC indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for GH Research PLC?
The principal executive office is located at Joshua Dawson House, Dawson Street, Dublin 2, D02 RY95, Ireland.
Filing Stats: 263 words · 1 min read · ~1 pages · Grade level 13.4 · Accepted 2025-10-09 07:13:44
Filing Documents
- ef20056751_6k.htm (6-K) — 10KB
- ef20056751_ex99-1.htm (EX-99.1) — 11KB
- 0001140361-25-037761.txt ( ) — 22KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2025. Commission File Number: 001-40530 GH Research PLC (Exact name of registrant as specified in its charter) Joshua Dawson House Dawson Street Dublin 2 D02 RY95 Ireland (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F Form 40-F GH Research PLC (the "Company") announces its participation at the 38 th European College of Neuropsychopharmacology (ECNP) annual meeting, which is scheduled to take place from October 11-14, 2025, in Amsterdam, the Netherlands. A copy of the press release is attached hereto as Exhibit 99.1. The fact that this press release is being made available should not be deemed an admission as to the materiality of any information contained therein. The information contained in the press release is being provided as of October 9, 2025, and the Company does not undertake any obligation to update the press release in the future or to update forward-looking statements to reflect subsequent actual results. 1 EXHIBIT INDEX 99.1 Press release dated October 9, 2025 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GH Research PLC Date: October 9, 2025 By: /s/ Julie Ryan Name: Julie Ryan Title: Vice President, Finance 3